Stock Groups

Abbott Labs CEO expects strong COVID-19 testing demand in near term -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO. A screen showing the Abbott Laboratories logo at New York Stock Exchange, New York City (USA), October 18, 2021. REUTERS/Brendan McDermid

(Reuters) – Abbott Laboratories (NYSE:) Robert Ford, Chief Executive Officer stated Tuesday that demand for COVID-19 tests has risen globally and sales should remain strong in the short term.

Ford stated that “We have, obviously, you know, had a fairly, quite strong last few months of testing” and that he expects this to continue in the immediate future at the J.P. Morgan Health Care conference.

He said that his company is able to meet demand.

Ford indicated that although testing demand is expected to decline eventually, Ford believes there will always be an adequate supply.

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.

[ad_2]